Table of Contents
<< Previous Issue | Dec 2008 (Vol: 2008, Issue: 103) | Next Issue >> |
- Section: Licensing
-
Novartis and Evotec to Identify and Develop Small Molecules
-
AstraZeneca Expands One Deal and Terminates Another
-
Bristol-Myers Squibb and Exelixis Sign Cancer Deal
-
Teva Invests in Yeast-based Drug Discovery Technology
-
Pfizer Gains European Rights to Specialist Biologic Product, Xiaflex
-
Dynavax’s Deal Termination with Merck is followed by a New Agreement with GSK
- Section: Research & Development
-
Synta Seals Deal in Inflammatory Diseases with Roche